Overview

Tirofiban for Reduction of Thromboembolic Events in Endovascular Unruptured Aneurysm Repair

Status:
RECRUITING
Trial end date:
2025-06-01
Target enrollment:
Participant gender:
Summary
To explore whether administering tirofiban in stent-assisted coiling/flow diverting treatments for participants with unruptured intracranial aneurysms can reduce new ischemic lesions on postoperative DWI sequences compared to conventional dual antiplatelet therapy.
Phase:
PHASE2
Details
Lead Sponsor:
Beijing Tiantan Hospital
Treatments:
Aspirin
Clopidogrel
Tirofiban